Tag: venture capital
-
Cell Engineering Company Launches, Raises $4.7 Million
A company designing biological circuits with techniques derived from computer-assisted design like those used in semiconductors is starting up in Cambridge, Massachusetts.
-
Cell Programming Company Raises $49.5M in Early Funds
A start-up enterprise creating add-on treatments that program the effects of cell and gene therapies is raising $49.5 million in its first venture funding round.
-
New Finance, Development Model for Pancreatic Disease
An organization is being formed to adopt performance-based financing and precision medicine to accelerate research and development on pancreatitis.
-
Neuro Disease Start-Up Gains $30M in Early Funds
A start-up enterprise developing treatments for several neurological diseases that the company says are triggered by a common destructive protein, is raising $30 million its first venture financing round.
-
3-D Organ Printing Company Gains Seed Funds
A start-up enterprise seeking to create replacement human tissue and organs with three-dimensional printing is raising $1.8 million in seed capital.
-
Synthetic DNA Start-Up Raises $13M in Early Funds
A company producing synthesized DNA for medical and other biotechnology applications is raising €11 million ($US 13 million) in its first venture funding round.
-
Start-Up Lands $10M for Gene-Editing HIV Treatments
A new enterprise developing treatments using gene editing to eliminate HIV infections received $10 million in its seed funding round.
-
Forensic Genomics Company Spun-Off From Illumina
A new company is being established to provide genomics analysis systems for law enforcement, spun-off from a leading maker of genomics systems.
-
University Spins Off Educational Robot Start-Up
A start-up enterprise spun-off from Harvard University is developing a learning system with robotics to teach computer coding to students.
-
Gene Editing, Therapy Company Gains $83.5M in Venture Funds
A biotechnology company designing treatments with gene edits and transfers using benign viruses is raising $83.5 million in its second venture funding round.